Back
Cidara Therapeutics, Inc. 10K Form
Buy
80
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.34
Seasonality Move:
5.32%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CDTX News And Ratings
See the #1 stock for the next 7 days that we like better than CDTX
CDTX Financial Statistics
Sales & Book Value
| Annual Sales: | $1.3M |
|---|---|
| Cash Flow: | $-40.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $14.40 |
| Price / Book: | 16.42 |
Profitability
| EPS (TTM): | -11.78360 |
|---|---|
| Net Income (TTM): | $-184.8M |
| Gross Margin: | $1M |
| Return on Equity: | -68.74% |
| Return on Assets: | -56.95% |
Cidara Therapeutics, Inc. Earnings Forecast
Key Cidara Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 12 years for CDTX is 81.73%.
-
The Selling, General & Administrative Expenses for CDTX have been equal to 1,616.86% of Gross Profit Margin.
-
The Research & Development expenses have been 5,637.57% of Revenue.
-
The Net Earning history of CDTX is -13,356.16% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 6 years.
Cidara Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CDTX |
| CUSIP: | 171757 |
| Website: | cidara.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.62 |
| Quick Ratio: | 4.47 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CDTX Technical Analysis vs Fundamental Analysis
Buy
80
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy or a Sell?
-
Cidara Therapeutics, Inc. stock is rated a BuyThe current Cidara Therapeutics, Inc. [CDTX] share price is $220.50. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.